Brazil Technovigilance Reporting Deadlines under RDC 67/2009

1. Key takeaways

Brazil’s technovigilance reporting clock is not a single deadline but four parallel windows. Deaths occurring in Brazil, serious threats to public health and counterfeiting must enter Notivisa within 72 hours of the registration holder becoming aware; the same categories occurring abroad but involving products imported into Brazil carry 10 calendar days; other confirmed serious adverse events, and non-serious adverse events whose recurrence could lead to a serious adverse event, also carry 10 calendar days; technical complaints that could lead to a serious adverse event carry 30 calendar days. GRZAN’s judgment: the window foreign manufacturers most often lose is the shortest one, because the starting point of awareness sits on the Brazilian holder’s side, and every day the information spends travelling from the factory to Brazil consumes the 72 hours.

2. Legal basis

• Technovigilance Regulation — RDC nº 67/2009, published on December 21, 2009 (DOU 2009-12-23), Article 8 and Article 10, as amended by RDC 557/2021 [single source: official consolidated AnvisaLegis text, not cross-checked against a second source]
• Classification, notification and registration of medical devices, and labeling and instructions-for-use requirements — RDC nº 751/2022, resolution of September 15, 2022, Article 4, item VIII and Article 60, §1
• Law on health offenses and sanctions — Lei nº 6.437/1977, dated August 20, 1977 and published in the DOU on August 24, 1977 (Part 1, page 11145), full text (list of sanctions)

3. Expert insights

The logic behind the four tiers deserves to be taken apart. The first tier places death, a serious threat to public health and counterfeiting side by side: three events with entirely different medical profiles are compressed into the same window, which shows that ANVISA is concerned with irreversible consequences and loss of control rather than with the clinical classification of the event itself. GRZAN repeatedly encounters one misjudgment in projects: filing a death that occurred abroad into the first tier. Under Article 8, only events occurring within Brazil fall under the 72 hours; events occurring abroad but involving a product already imported into Brazil fall under the 10 calendar days tier.

The second premise is the definition of a serious adverse event. Article 4 of RDC 67/2009 defines it in five categories: death, permanent impairment, the need for medical or surgical intervention, hospitalization or prolongation of hospitalization, and fetal damage. GRZAN recommends running the initial triage at the factory against these five items and quickly diverting events that clearly do not belong, so that an event that genuinely requires a 72-hour response is not drowned by ordinary complaints.

The trigger conditions of the fourth tier are what GRZAN most recommends internalizing. A technical complaint enters the 30 calendar days tier as soon as any one of the following applies: recurrence is not rare; the same type of event caused death or serious health damage within the last two years; corrective action is required; or the design or the labeling and instructions for use could lead to use error. This is not a clinical judgment but a combined judgment on the product and its history, and it needs records to support it.

The layer of the responsible party is often missed. The single paragraph of Article 3 of RDC 67/2009 makes the registration holder the legally responsible party for products under its name, required to answer to health authorities for technical complaints, adverse events, serious threats to public health, alerts and field actions; the resolution applies to holders with an establishment in Brazil. GRZAN has seen foreign factories draft the Portuguese submission directly while the holder only stamps it; once the content does not match the facts, responsibility and consequences fall entirely on the holder’s side. Note also that the resolution has already been amended by RDC 557/2021, so when internal SOPs cite its articles, verify the current text against the DOU.

The exemptions of Article 10 are just as easily misused. Events arising entirely from the patient’s own disease, use after expiry, and minor reactions already anticipated in the instructions for use can be exempted from reporting; but as soon as a serious threat to public health is involved, no exemption applies at all. GRZAN treats an exemption as an exception that requires written justification, not as a reason not to report — the exemption decision must be completed within the reporting deadline and documented; otherwise the delay itself constitutes a violation.

4. Practical recommendations

• Build a direct event channel between the Brazilian registration holder and the foreign factory, and fix the moment of awareness in a written record.
• Prepare Portuguese SOP templates against the four tiers in advance; once the first tier is triggered, start immediately and do not wait for the complete investigation conclusion.
• Complete the four determinations for technical complaints at the time of filing, and retain the basis for each determination.
• Keep written justification and signature records for every exemption decision.
• Turn the five definitions of serious adverse events in Article 4 into a factory-side triage checklist, kept aligned with the Brazilian side.
• Run an unannounced deadline drill at regular intervals to verify end-to-end elapsed time across the chain.
• Archive submission records by the four tiers, so they can be traced and presented during later inspections.

5. Verification checklist

GRZAN also recommends setting a time-zone rule for the event intake log on the holder’s side: use the moment of awareness in Brazilian local time as the starting point of the four clocks, and register the factory-side moment of awareness in the same record. With the two time points side by side, it is possible afterwards to explain whether the transmission time was reasonable, and to present a verifiable evidence chain when ANVISA asks why the submission was not made within 72 hours. For drills, GRZAN recommends at least once a year, covering both the foreign and the domestic paths.

• □ Confirm the reporting party is the Brazilian registration holder (detentor de registro / detentor de notificação), not the foreign factory
• □ Verify whether the event falls into the 72 hours tier, and check the place of occurrence
• □ Verify the four trigger determinations for technical complaints
• □ Verify whether an Article 10 exemption is invoked, and that the exemption has not been invalidated by a serious threat to public health
• □ Verify that the scope of responsibility covers registration holders with an establishment in Brazil
• □ Verify that submission records have been archived by the four tiers
• □ Verify the current text of Article 8 of RDC 67/2009 against the DOU (including the RDC 557/2021 amendment)

Regulatory information verified as of October 29, 2026

GRZAN Regulatory Team

GRZAN supports medical device manufacturers across the full Brazilian post-market compliance lifecycle: technovigilance and Notivisa reporting, field actions and recalls, inventory depletion management, UDI and SIUD obligations, and ANVISA inspection readiness and response. Our regulatory team keeps your Brazilian registrations, vigilance files and corrective-action records aligned with current ANVISA requirements, so that every deadline and every record can withstand scrutiny. For post-market compliance support in the Brazilian market, contact info@grzanglobal.com.